|
第七章參考文獻
Alabadi, J.A., Torregrosa, G., Miranda, F.J., Salom, J.B., Centeno, J.M., Alborch, E., 1997, Impairment of the modulatory role of nitric oxide on the endothelin-1-elicited contraction of cerebral arteries: a pathogenetic factor in cerebral vasospasm after subarachnoid hemorrhage? Neurosurgery 41:245-252
Alafaci, C., Salpietro, F.M., Iacopino, D.G., Edvinsson, L., Tomasello, F., 1991, Endothelin: an endothelium-derived vasoactive peptide and its possible role in the pathogenesis of cerebral vasospasm. Ital J Neurol Sci 12:55-58.
Alonso, D., Radomski, M.W., 2003, The nitric oxide-endothelin-1 connection. Heart Fail Rev 8:107-115.
Amit Agrawal, J.T., Lekha Pandit, Anand Kumar, G.K. Singh, R. Lakshmi, 2007, Neurogenic pulmonary oedema. Eur J Gen Med 4:25-32.
Asano, T., Ikegaki, I., Suzuki, Y., Satoh, S., Shibuya, M., 1989, Endothelin and the production of cerebral vasospasm in dogs. Biochem Biophys Res Commun 159:1345-1351.
Asano, T., Ikegaki, I., Satoh, S., Suzuki, Y., Shibuya, M., Sugita, K., Hidaka, H., 1990, Endothelin: a potential modulator of cerebral vasospasm. Eur J Pharmacol 190:365-372.
Barandier, C., Ming, X.F., Rusconi, S., Yang, Z., 2003, PKC is required for activation of ROCK by RhoA in human endothelial cells. Biochemical and biophysical research communications 304:714-719.
Barth, M., Capelle, H.H., Munch, E., Thome, C., Fiedler, F., Schmiedek, P., Vajkoczy, P., 2007, Effects of the selective endothelin A (ET(A)) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage - preliminary results from a randomized clinical series. Acta Neurochir (Wien) 149:911-918; discussion 918.
Battistini, B., Dussault, P., 1998, Blocking of the endothelin system: the development of receptor antagonists. Pulm Pharmacol Ther 11:97-112.
Bertsch, T., Kuehl, S., Muehlhauser, F., Walter, S., Hodapp, B., Rossol, S., Schmeck, J., Ragoschke, A., Schutt, S., Fritzinger, M., Horn, P., Vajkoczy, P., Wellner, M.W., Fassbender, K., 2001, Source of endothelin-1 in subarachnoid hemorrhage. Clin Chem Lab Med 39:341-345.
Bird, J.E., Webb, M.L., Wasserman, A.J., Liu, E.C., Giancarli, M.R., Durham, S.K., 1995, Comparison of a novel ETA receptor antagonist and phosphoramidon in renal ischemia. Pharmacology 50:9-23.
Chabrier, P.E., Braquet, P., 1990, Endothelin. Horm Res 34:169-174.
Chang, C., Pan, W., 1991, 腦中風的分子流行病學. 科學月刊 262.
Chang, C.Z., Yen, C.P., Winadi, D., Wu, S.C., Howng, S.L., Lin, T.K., Jeng, A.Y., Kassell, N.F., Kwan, A.L., 2004, Neuroprotective Effect of CGS 26303, an Endothelin-converting Enzyme Inhibitor, on Transient Middle Cerebral Artery Occlusion in Rats. Journal of cardiovascular pharmacology 44:S487-S489.
Chou, A.K., Chen, T.I., Winardi, W., Dai, M.H., Chen, S.C., Howng, S.L., Yen, C.P., Lin, T.K., Jeng, A.Y., Kwan, A.L., 2007, Functional neuroprotective effect of CGS 26303, a dual ECE inhibitor, on ischemic-reperfusion spinal cord injury in rats. Exp Biol Med (Maywood) 232:214-218.
Chow, M., Dumont, A.S., Kassell, N.F., 2002, Endothelin receptor antagonists and cerebral vasospasm: an update. Neurosurgery 51:1333-1341; discussion 1342.
Cirak, B., Kiymaz, N., Ari, H.H., Ugras, S., 2004, The effects of endothelin antagonist BQ-610 on cerebral vascular wall following experimental subarachnoid hemorrhage and cerebral vasospasm. Clin Auton Res 14:197-201.
Clozel, M., Watanabe, H., 1993, BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection. Life Sci 52:825-834.
Clozel, M., Breu, V., Burri, K., Cassal, J.M., Fischli, W., Gray, G.A., Hirth, G., Loffler, B.M., Muller, M., Neidhart, W., et al., 1993, Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature 365:759-761.
Crowley, R.W., Medel, R., Kassell, N.F., Dumont, A.S., 2008, New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage. Drug Discov Today 13:254-260.
D''Orleans-Juste, P., Plante, M., Honore, J.C., Carrier, E., Labonte, J., 2003, Synthesis and degradation of endothelin-1. Can J Physiol Pharmacol 81:503-510.
Davis, K.L., Martin, E., Turko, I.V., Murad, F., 2001, Novel effects of nitric oxide. Annu Rev Pharmacol Toxicol 41:203-236.
Denninger, J.W., Marletta, M.A., 1999, Guanylate cyclase and the .NO/cGMP signaling pathway. Biochim Biophys Acta 1411:334-350.
Department of Health, 2006, 台灣十大死因分析. 衛生統計資訊網.
Doggrell, S.A., 2002, The therapeutic potential of endothelin-1 receptor antagonists and endothelin-converting enzyme inhibitors on the cardiovascular system. Expert Opin Investig Drugs 11:1537-1552.
Fassbender, K., Hodapp, B., Rossol, S., Bertsch, T., Schmeck, J., Schutt, S., Fritzinger, M., Horn, P., Vajkoczy, P., Kreisel, S., Brunner, J., Schmiedek, P., Hennerici, M., 2001, Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry 70:534-537.
Fassbender, K., Hodapp, B., Rossol, S., Bertsch, T., Schmeck, J., Schutt, S., Fritzinger, M., Horn, P., Vajkoczy, P., Wendel-Wellner, M., Ragoschke, A., Kuehl, S., Brunner, J., Schurer, L., Schmiedeck, P., Hennerici, M., 2000, Endothelin-1 in subarachnoid hemorrhage: An acute-phase reactant produced by cerebrospinal fluid leukocytes. Stroke 31:2971-2975.
Fox, J.L., Ko, J.P., 1978, Cerebral vasospasm: a clinical observation. Surg Neurol 10:269-275.
Gilbert, P., Tremblay, J., Thorin, E., 2001, Endothelium-derived endothelin-1 reduces cerebral artery sensitivity to nitric oxide by a protein kinase C-independent pathway. Stroke 32:2351-2355.
Gray, H., Lewis, W.H., 1918, Anatomy of the Human Body. Bartleby com 6:146.
Hashimoto, R., Nakamura, Y., Kosako, H., Amano, M., Kaibuchi, K., Inagaki, M., Takeda, M., 1999, Distribution of Rho-kinase in the bovine brain. Biochem Biophys Res Commun 263:575-579.
Hirata, K., Kuroda, R., Sakoda, T., Katayama, M., Inoue, N., Suematsu, M., Kawashima, S., Yokoyama, M., 1995, Inhibition of endothelial nitric oxide synthase activity by protein kinase C. Hypertension 25:180-185.
Howng, S.L., Hung, T.P., Kwan, A.L., Lin, C.L., 1995, [Intracranial aneurysm in Taiwan]. J Formos Med Assoc 94 Suppl 2:S73-80.
Hu, H.H., Sheng, W.Y., Chu, F.L., Lan, C.F., Chiang, B.N., 1992, Incidence of stroke in Taiwan. Stroke 23:1237-1241.
Huang, T., 1998, 頭痛與腦動脈瘤破裂. 高醫醫訊 17.
Ide, K., Yamakawa, K., Nakagomi, T., Sasaki, T., Saito, I., Kurihara, H., Yosizumi, M., Yazaki, Y., Takakura, K., 1989, The role of endothelin in the pathogenesis of vasospasm following subarachnoid haemorrhage. Neurol Res 11:101-104.
Jeng, A.Y., Mulder, P., Kwan, A.L., Battistini, B., 2002, Nonpeptidic endothelin-converting enzyme inhibitors and their potential therapeutic applications. Can J Physiol Pharmacol 80:440-449.
Kamata, K., Nishiyama, H., Miyata, N., Kasuya, Y., 1991, Changes in responsiveness of the canine basilar artery to endothelin-1 after subarachnoid hemorrhage. Life Sci 49:217-224.
Kaohsiung veterans general hospital, 2003, 腦中風簡介. 高雄榮民總醫院衛生教育資源.
Karadeniz, U., Erdemli, O., Ozatik, M.A., Yamak, B., Demirci, A., Kucuker, S.A., Saritas, A., Tasdemir, O., 2005, Assessment of cerebral blood flow with transcranial Doppler in right brachial artery perfusion patients. Ann Thorac Surg 79:139-146; discussion 146.
Karlsberg, P., Adams, J.E., Elliot, H.W., 1962, Inhibition and reversal of serotonin-induced cerebral vasospasm. Surg Forum 13:425-427.
Kasuya, H., Weir, B.K., Nakane, M., Pollock, J.S., Johns, L., Marton, L.S., Stefansson, K., 1995, Nitric oxide synthase and guanylate cyclase levels in canine basilar artery after subarachnoid hemorrhage. J Neurosurg 82:250-255.
Katzung, B., 2004, Dactinomycin. Basic & Clinical pharmacology (8 edition):938-939.
Kawanabe, Y., Masaki, T., Hashimoto, N., 2006, Involvement of phospholipase C in endothelin 1-induced stimulation of Ca++ channels and basilar artery contraction in rabbits. J Neurosurg 105:288-293.
Kawano, Y., Yoshimura, T., Kaibuchi, K., 2002, [Involvement of small GTPase Rho in cardiovascular diseases]. Nippon Yakurigaku Zasshi 120:149-158.
Kessler, I.M., Pacheco, Y.G., Lozzi, S.P., de Araujo, A.S., Jr., Onishi, F.J., de Mello, P.A., 2005, Endothelin-1 levels in plasma and cerebrospinal fluid of patients with cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Surgical neurology 64 Suppl 1:S1:2-5; discussion S1:5.
Kobayashi, H., Hayashi, M., Kobayashi, S., Kabuto, M., Handa, Y., Kawano, H., Ide, H., 1991, Cerebral vasospasm and vasoconstriction caused by endothelin. Neurosurgery 28:673-678; discussion 678-679.
Kolb, E., 1991, [Endothelins--properties, formation, mechanism of action and significance]. Z Gesamte Inn Med 46:355-360.
Kuo, J.F., Shoji, M., Kuo, W.N., 1978, Molecular and physiopathologic aspects of mammalian cyclic GMP-dependent protein kinase. Annu Rev Pharmacol Toxicol 18:341-355.
Kwan, A.L., Bavbek, M., Jeng, A.Y., Toyoda, T., Kassell, N.F., Lee, K.S., 1998, Attenuation of experimental subarachnoid hemorrhage-induced cerebral vasospasm by CGS 26303, an endothelin-converting enzyme inhibitor. J Cardiovasc Pharmacol 31 Suppl 1:S320-322.
Kwan, A.L., Lin, C.L., Chang, C.Z., Wu, S.C., Howng, S.L., Jeng, A.Y., 2002, Attenuation of SAH-induced cerebral vasospasm by a selective ECE inhibitor. Neuroreport 13:197-199.
Kwan, A.L., Lin, C.L., Yen, C.P., Winardi, W., Su, Y.F., Winardi, D., Dai, Z.K., Jeng, A.Y., Kassell, N.F., Howng, S.L., Wang, C.J., 2006, Prevention and reversal of vasospasm and ultrastructural changes in basilar artery by continuous infusion of CGS 35066 following subarachnoid hemorrhage. Exp Biol Med (Maywood) 231:1069-1074.
Laher, I., Zhang, J.H., 2001, Protein kinase C and cerebral vasospasm. J Cereb Blood Flow Metab 21:887-906.
Lai, A., Frishman, W.H., 2005, Rho-kinase inhibition in the therapy of cardiovascular disease. Cardiol Rev 13:285-292.
Lan, C., Das, D., Wloskowicz, A., Vollrath, B., 2004, Endothelin-1 modulates hemoglobin-mediated signaling in cerebrovascular smooth muscle via RhoA/Rho kinase and protein kinase C. American journal of physiology 286:H165-173.
Lee, R.M., 1995, Morphology of cerebral arteries. Pharmacol Ther 66:149-173.
Levesque, H., Sevrain, L., Freger, P., Tadie, M., Courtois, H., Creissard, P., 1990, Raised plasma endothelin in aneurysmal subarachnoid haemorrhage. Lancet 335:290.
Levin, E.R., 1995, Endothelins. N Engl J Med 333:356-363.
Li, L., Eto, M., Lee, M.R., Morita, F., Yazawa, M., Kitazawa, T., 1998, Possible involvement of the novel CPI-17 protein in protein kinase C signal transduction of rabbit arterial smooth muscle. J Physiol 508 ( Pt 3):871-881.
Lin, C., 2006, 最可怕的腦出血性中風--顱內動脈瘤破裂引起的蜘蛛膜下腔出血. 高醫醫訊 26.
Lin, C.L., Jeng, A.Y., Howng, S.L., Kwan, A.L., 2004, Endothelin and subarachnoid hemorrhage-induced cerebral vasospasm: pathogenesis and treatment. Curr Med Chem 11:1779-1791.
Lin, C.L., Winardi, W., Jeng, A.Y., Kwan, A.L., 2006, Endothelin-converting enzyme inhibitors for the treatment of subarachnoid hemorrhage-induced vasospasm. Neurol Res 28:721-729.
Lin, C.L., Kwan, A.L., Dumont, A.S., Su, Y.F., Kassell, N.F., Wang, C.J., Wu, S.C., Kuo, C.L., Huang, C.S., Jeng, A.Y., Liu, C.S., 2007, Attenuation of experimental subarachnoid hemorrhage-induced increases in circulating intercellular adhesion molecule-1 and cerebral vasospasm by the endothelin-converting enzyme inhibitor CGS 26303. J Neurosurg 106:442-448.
Loirand, G., Guilluy, C., Pacaud, P., 2006a, Regulation of Rho proteins by phosphorylation in the cardiovascular system. Trends Cardiovasc Med 16:199-204.
Loirand, G., Guerin, P., Pacaud, P., 2006b, Rho kinases in cardiovascular physiology and pathophysiology. Circ Res 98:322-334.
Lopez, A., 2006, The top 10 causes of death: Deaths across the globe: An overview. The Lancet 367:1747-1757.
Lucas, K.A., Pitari, G.M., Kazerounian, S., Ruiz-Stewart, I., Park, J., Schulz, S., Chepenik, K.P., Waldman, S.A., 2000, Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 52:375-414.
Macdonald, R.L., Pluta, R.M., Zhang, J.H., 2007, Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution. Nat Clin Pract Neurol 3:256-263.
Macdonald, R.L., Johns, L., Lin, G., Marton, L.S., Hallak, H., Marcoux, F., Kowalczuk, A., 1998, Prevention of vasospasm after subarachnoid hemorrhage in dogs by continuous intravenous infusion of PD156707. Neurol Med Chir (Tokyo) 38 Suppl:138-145.
Mascia, L., Fedorko, L., Stewart, D.J., Mohamed, F., terBrugge, K., Ranieri, V.M., Wallace, M.C., 2001, Temporal relationship between endothelin-1 concentrations and cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. Stroke 32:1185-1190.
Mathiesen, T., Edner, G., Ulfarsson, E., Andersson, B., 1997, Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage. J Neurosurg 87:215-220.
Matsui, T., Sugawa, M., Johshita, H., Takuwa, Y., Asano, T., 1991, Activation of the protein kinase C-mediated contractile system in canine basilar artery undergoing chronic vasospasm. Stroke 22:1183-1187.
Mayer, S.A., Fink, M.E., Homma, S., Sherman, D., LiMandri, G., Lennihan, L., Solomon, R.A., Klebanoff, L.M., Beckford, A., Raps, E.C., 1994, Cardiac injury associated with neurogenic pulmonary edema following subarachnoid hemorrhage. Neurology 44:815-820.
Mellin, V., Jeng, A.Y., Monteil, C., Renet, S., Henry, J.P., Thuillez, C., Mulder, P., 2005, Triple ACE-ECE-NEP inhibition in heart failure: a comparison with ACE and dual ECE-NEP inhibition. J Cardiovasc Pharmacol 46:390-397.
Mergia, E., Friebe, A., Dangel, O., Russwurm, M., Koesling, D., 2006, Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system. J Clin Invest 116:1731-1737.
Miao, L., Dai, Y., Zhang, J., 2002, Mechanism of RhoA/Rho kinase activation in endothelin-1- induced contraction in rabbit basilar artery. Am J Physiol Heart Circ Physiol 283:H983-989.
Mima, T., Mostafa, M.G., Mori, K., 1997, Therapeutic dose and timing of administration of RNA synthesis inhibitors for preventing cerebral vasospasm after subarachnoid hemorrhage. Acta Neurochir Suppl 70:65-67.
Miyauchi, T., Tomobe, Y., Shiba, R., Ishikawa, T., Yanagisawa, M., Kimura, S., Sugishita, Y., Ito, I., Goto, K., Masaki, T., 1990, Involvement of endothelin in the regulation of human vascular tonus. Potent vasoconstrictor effect and existence in endothelial cells. Circulation 81:1874-1880.
Mizuno, Y., Isotani, E., Ohno, K., Nagai, A., Imamura, M., Azuma, H., 2008, Involvement of accumulated NOS inhibitors and endothelin-1, enhanced arginase, and impaired DDAH activities in pulmonary dysfunction following subarachnoid hemorrhage in the rabbit. Vascul Pharmacol 48:21-31.
Mostafa, M.G., Mima, T., Taniguchi, T., Mori, K., 2000, Doxorubicin, an RNA synthesis inhibitor, prevents vasoconstriction and inhibits aberrant expression of endothelin-1 in the cerebral vasospasm model of the rat. Neurosci Lett 283:197-200.
Mulder, P., Barbier, S., Monteil, C., Jeng, A.Y., Henry, J.P., Renet, S., Thuillez, C., 2004, Sustained improvement of cardiac function and prevention of cardiac remodeling after long-term dual ECE-NEP inhibition in rats with congestive heart failure. J Cardiovasc Pharmacol 43:489-494.
Nakagomi, T., Ide, K., Yamakawa, K., Sasaki, T., Kurihara, H., Saito, I., Takakura, K., 1989, Pharmacological effect of endothelin, an endothelium-derived vasoconstrictive peptide, on canine basilar arteries. Neurol Med Chir (Tokyo) 29:967-974.
National health insurance, 2005, 全民健康保險重大傷病範圍. 中央健康保險局
Nayler, W.G., 1990, Endothelin: isoforms, binding sites and possible implications in pathology. Trends Pharmacol Sci 11:96-99.
Nishizawa, S., Nezu, N., Uemura, K., 1992, Direct evidence for a key role of protein kinase C in the development of vasospasm after subarachnoid hemorrhage. J Neurosurg 76:635-639.
Nishizawa, S., Yamamoto, S., Yokoyama, T., Ryu, H., Uemura, K., 1995, Chronological changes of arterial diameter, cGMP, and protein kinase C in the development of vasospasm. Stroke 26:1916-1920; discussion 1920-1911.
Nishizawa, S., Chen, D., Yokoyama, T., Yokota, N., Otha, S., 2000, Endothelin-1 initiates the development of vasospasm after subarachnoid haemorrhage through protein kinase C activation, but does not contribute to prolonged vasospasm. Acta neurochirurgica 142:1409-1415.
Nogueira, R.G., Bodock, M.J., Koroshetz, W.J., Topcuoglu, M.A., Carter, B.S., Ogilvy, C.S., Pryor, J.C., Buonanno, F.S., 2007, High-dose bosentan in the prevention and treatment of subarachnoid hemorrhage-induced cerebral vasospasm: an open-label feasibility study. Neurocrit Care 7:194-202.
Obara, K., Nishizawa, S., Koide, M., Nozawa, K., Mitate, A., Ishikawa, T., Nakayama, K., 2005, Interactive role of protein kinase C-delta with rho-kinase in the development of cerebral vasospasm in a canine two-hemorrhage model. J Vasc Res 42:67-76.
Ohkuma, H., Parney, I., Megyesi, J., Ghahary, A., Findlay, J.M., 1999, Antisense preproendothelin-oligoDNA therapy for vasospasm in a canine model of subarachnoid hemorrhage. J Neurosurg 90:1105-1114.
Paoletti, R., Cignarella, A., 2007, Increasingly selective pharmacologic targets in cardiovascular disease. Curr Atheroscler Rep 9:89-90.
Park, K.W., Metais, C., Dai, H.B., Comunale, M.E., Sellke, F.W., 2001, Microvascular endothelial dysfunction and its mechanism in a rat model of subarachnoid hemorrhage. Anesth Analg 92:990-996.
Pham, D., Jeng, A.Y., Plante, S., Escher, E., Battistini, B., 2002, Inhibition of endothelin-converting enzyme for protection against neointimal proliferation following balloon angioplasty of the rat carotid artery. Can J Physiol Pharmacol 80:450-457.
Poulat, P., Couture, R., 1998, Increased pulmonary vascular permeability and oedema induced by intrathecally injected endothelins in rat. Eur J Pharmacol 344:251-259.
Ramzy, D., Rao, V., Tumiati, L.C., Xu, N., Sheshgiri, R., Miriuka, S., Delgado, D.H., Ross, H.J., 2006, Elevated endothelin-1 levels impair nitric oxide homeostasis through a PKC-dependent pathway. Circulation 114:I319-326.
Randell, T., Tanskanen, P., Scheinin, M., Kytta, J., Ohman, J., Lindgren, L., 1999, QT dispersion after subarachnoid hemorrhage. J Neurosurg Anesthesiol 11:163-166.
Rikitake, Y., Liao, J.K., 2005, ROCKs as therapeutic targets in cardiovascular diseases. Expert Rev Cardiovasc Ther 3:441-451.
Rikitake, Y., Kim, H.H., Huang, Z., Seto, M., Yano, K., Asano, T., Moskowitz, M.A., Liao, J.K., 2005, Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Stroke 36:2251-2257.
Rubanyi, G.M., Polokoff, M.A., 1994, Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46:325-415.
Russell, F.D., Davenport, A.P., 1999, Secretory pathways in endothelin synthesis. Br J Pharmacol 126:391-398.
Saito, A., Nakazawa, T., 1989, Cerebral vasospasm model produced by subarachnoid blood injection in dogs. Jpn J Pharmacol 50:250-252.
Savage, P., De Lombaert, S., Shimada, K., Tanzawa, K., Jeng, A.Y., 1998, Differential inhibition of wild-type endothelin-converting enzyme-1 and its mutants. J Cardiovasc Pharmacol 31 Suppl 1:S16-18.
Schomer, D.F., Marks, M.P., Steinberg, G.K., Johnstone, I.M., Boothroyd, D.B., Ross, M.R., Pelc, N.J., Enzmann, D.R., 1994, The anatomy of the posterior communicating artery as a risk factor for ischemic cerebral infarction. N Engl J Med 330:1565-1570.
Seto, M., Takuwa, Y., Sasaki, Y., 1999, [The molecular mechanism of vasospasm and the attenuation by fasudil]. Nippon Yakurigaku Zasshi 114 Suppl 1:66P-70P.
Shaw, M.D., Vermeulen, M., Murray, G.D., Pickard, J.D., Bell, B.A., Teasdale, G.M., 2000, Efficacy and safety of the endothelin, receptor antagonist TAK-044 in treating subarachnoid hemorrhage: a report by the Steering Committee on behalf of the UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group. J Neurosurg 93:992-997.
Shibuya, M., Hirai, S., Seto, M., Satoh, S., Ohtomo, E., 2005, Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial. J Neurol Sci 238:31-39.
Shigeno, T., Mima, T., Yanagisawa, M., Saito, A., Goto, K., Yamashita, K., Takenouchi, T., Matsuura, N., Yamasaki, Y., Yamada, K., et al., 1991a, Prevention of cerebral vasospasm by actinomycin D. J Neurosurg 74:940-943.
Shigeno, T., Mima, T., Yanagisawa, M., Saito, A., Fujimori, A., Shiba, R., Goto, K., Kimura, S., Yamashita, K., Yamasaki, Y., et al., 1991b, Possible role of endothelin in the pathogenesis of cerebral vasospasm. J Cardiovasc Pharmacol 17 Suppl 7:S480-483.
Shimokawa, H., Takeshita, A., 2005, Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscler Thromb Vasc Biol 25:1767-1775.
Shimokawa, H., Rashid, M., 2007, Development of Rho-kinase inhibitors for cardiovascular medicine. Trends Pharmacol Sci 28:296-302.
Sluck, J.M., Lin, R.C., Katolik, L.I., Jeng, A.Y., Lehmann, J.C., 1999, Endothelin converting enzyme-1-, endothelin-1-, and endothelin-3-like immunoreactivity in the rat brain. Neuroscience 91:1483-1497.
Sobey, C.G., Faraci, F.M., 1998, Subarachnoid haemorrhage: what happens to the cerebral arteries? Clin Exp Pharmacol Physiol 25:867-876.
Somlyo, A.P., Somlyo, A.V., 2003, Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83:1325-1358.
Stewart, D.J., 1991, Role of EDRF and endothelin in coronary vasomotor control. Basic Res Cardiol 86 Suppl 2:77-87.
Stone, J.R., Marletta, M.A., 1995, Heme stoichiometry of heterodimeric soluble guanylate cyclase. Biochemistry 34:14668-14674.
Suhardja, A., 2004, Mechanisms of disease: roles of nitric oxide and endothelin-1 in delayed cerebral vasospasm produced by aneurysmal subarachnoid hemorrhage. Nat Clin Pract Cardiovasc Med 1:110-116; quiz 112 p following 116.
Sundt, T.M., Jr., 1975, Management of ischemic complications after subarachnoid hemorrhage. J Neurosurg 43:418-425.
Suzuki, H., Sato, S., Suzuki, Y., Oka, M., Tsuchiya, T., Iino, I., Yamanaka, T., Ishihara, N., Shimoda, S., 1990, Endothelin immunoreactivity in cerebrospinal fluid of patients with subarachnoid haemorrhage. Ann Med 22:233-236.
Suzuki, R., Masaoka, H., Hirata, Y., Marumo, F., Isotani, E., Hirakawa, K., 1992, The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 77:96-100.
Tachibana, E., Harada, T., Shibuya, M., Saito, K., Takayasu, M., Suzuki, Y., Yoshida, J., 1999, Intra-arterial infusion of fasudil hydrochloride for treating vasospasm following subarachnoid haemorrhage. Acta Neurochir (Wien) 141:13-19.
Taiwan stroke society, 2003, 顱內動脈瘤破裂導致自發性蜘蛛膜下腔出血之一般處理原則. 台灣腦中風學會
Tanazawa, T., Suzuki, Y., Anzai, M., Tsugane, S., Takayasu, M., Shibuya, M., 1996, Vasodilation by intrathecal lipopolysaccharide of the cerebral arteries after subarachnoid haemorrhage in dogs. Acta Neurochir (Wien) 138:330-337.
Tanoi, C., Suzuki, Y., Shibuya, M., Sugita, K., Masuzawa, K., Asano, M., 1991, Mechanism of the enhanced vasoconstrictor responses to endothelin-1 in canine cerebral arteries. J Cereb Blood Flow Metab 11:371-379.
Tikkanen, I., Tikkanen, T., Cao, Z., Allen, T.J., Davis, B.J., Lassila, M., Casley, D., Johnston, C.I., Burrell, L.M., Cooper, M.E., 2002, Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes. J Hypertens 20:707-714.
Tseng, W., 1974, 中國人動脈硬化性心臟病及腦血管疾病之流行病學研究. 行政院衛生署及國立台灣大學醫學院.
Uchida, Y., Ninomiya, H., Saotome, M., Nomura, A., Ohtsuka, M., Yanagisawa, M., Goto, K., Masaki, T., Hasegawa, S., 1988, Endothelin, a novel vasoconstrictor peptide, as potent bronchoconstrictor. Eur J Pharmacol 154:227-228.
Vajkoczy, P., Meyer, B., Weidauer, S., Raabe, A., Thome, C., Ringel, F., Breu, V., Schmiedek, P., 2005, Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg 103:9-17.
Vermeersch, P., Buys, E., Pokreisz, P., Marsboom, G., Ichinose, F., Sips, P., Pellens, M., Gillijns, H., Swinnen, M., Graveline, A., Collen, D., Dewerchin, M., Brouckaert, P., Bloch, K.D., Janssens, S., 2007, Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia. Circulation 116:936-943.
VGH-KS, K.V.G.H.高., 2003, 腦中風簡介. 高雄榮民總醫院衛生教育資源.
Voldby, B., Engbaek, F., Enevoldsen, E.M., 1982, CSF serotonin concentrations and cerebral arterial spasm in patients with ruptured intracranial aneurysm. Stroke 13:184-189.
Wada, A., Tsutamoto, T., Ohnishi, M., Sawaki, M., Fukai, D., Maeda, Y., Kinoshita, M., 1999, Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism. Circulation 99:570-577.
Wanebo, J.E., Arthur, A.S., Louis, H.G., West, K., Kassell, N.F., Lee, K.S., Helm, G.A., 1998, Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm. Neurosurgery 43:1409-1417; discussion 1417-1408.
Webb, D.J., Monge, J.C., Rabelink, T.J., Yanagisawa, M., 1998, Endothelin: new discoveries and rapid progress in the clinic. Trends in pharmacological sciences 19:5-8.
Wettschureck, N., Offermanns, S., 2002, Rho/Rho-kinase mediated signaling in physiology and pathophysiology. J Mol Med 80:629-638.
World health organization, W., 2005, The top 10 cause of death.
Yamaura, I., Tani, E., Maeda, Y., Minami, N., Shindo, H., 1992, Endothelin-1 of canine basilar artery in vasospasm. J Neurosurg 76:99-105.
Yen, C.P., Chen, S.C., Lin, T.K., Wu, S.C., Chang, C.Y., Lue, S.I., Jeng, A.Y., Kassell, N.F., Kwan, A.L., 2004, CGS 26303 Upregulates mRNA Expression of Heme Oxygenase-1 in Brain Tissue of Rats Subjected to Experimental Subarachnoid Hemorrhage. J Cardiovasc Pharmacol 44:S474-S478.
Zervas, N.T., Candia, M., Candia, G., Kido, D., Pessin, M.S., Rosoff, C.B., Bacon, V., 1979, Reduced incidence of cerebral ischemia following rupture of intracranial aneurysms. Surg Neurol 11:339-344.
Zhao, Z., Rivkees, S.A., 2003, Rho-associated kinases play an essential role in cardiac morphogenesis and cardiomyocyte proliferation. Dev Dyn 226:24-32.
Zimmermann, M., Seifert, V., 1998, Endothelin and subarachnoid hemorrhage: an overview. Neurosurgery 43:863-875; discussion 875-866.
Zimmermann, M., Seifert, V., 2004, Endothelin receptor antagonists and cerebral vasospasm. Clin Auton Res 14:143-145.
Zubkov, A.Y., Rollins, K.S., Parent, A.D., Zhang, J., Bryan, R.M., Jr., 2000, Mechanism of endothelin-1-induced contraction in rabbit basilar artery. Stroke 31:526-533.
Zuccarello, M., Boccaletti, R., Romano, A., Rapoport, R.M., 1998, Endothelin B receptor antagonists attenuate subarachnoid hemorrhage-induced cerebral vasospasm. Stroke 29:1924-1929.
|